Preoperative intravitreal bevacizumab use as an adjuvant to diabetic vitrectomy: histopathologic findings and clinical implications. [electronic resource]
Producer: 20110606Description: 636-41 p. digitalISSN:- 1549-4713
- Actins -- metabolism
- Adult
- Aged
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antigens, CD34 -- metabolism
- Bevacizumab
- Collagen -- metabolism
- Combined Modality Therapy
- Diabetic Retinopathy -- metabolism
- Epiretinal Membrane -- metabolism
- Female
- Humans
- Immunoenzyme Techniques
- Intravitreal Injections
- Male
- Middle Aged
- Preoperative Care
- Prospective Studies
- Retinal Neovascularization -- metabolism
- Tomography, Optical Coherence
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Vitrectomy
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.